INSMED INC
INSMNASDAQ🏆 #372 by market capUS Equity
$132.61▼ $2.14 (−1.61%)
Market closed · at close1h—
24h▼ 1.6%
7d▲ 34.2%
14d▲ 28.5%
30d▲ 21.5%
1y▲ 8.8%
🏦Market Cap
$28.74B
Mid Cap
📈Revenue Growth (YoY)
+185.8%
High Growth
📊Gross Margin
83.5%
High
💵FCF Margin
—
⚖️P/S Ratio
25.5x
Expensive
Otter Score
49
Weak
Trading Snapshot
- Day Range
- $131.02 – $134.99
- 52-Week Range
- $90.39 – $212.75
- Volume
- $2.13B
- Avg Volume
- $2.25B
- Shares Outstanding
- 216.8M
- Next Earnings
- Oct 11, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.13B
- Last Q Revenue
- $302M
- P/E Ratio
- —
- P/S Ratio
- 25.5x
- EPS (TTM)
- $-4.10
- Dividend Yield
- —
Why Investors Own INSM
- ✓High-growth profile — revenue up +57.1% YoY with expanding US Equity exposure.
- ✓Healthy economics — 28% gross margin and 16% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$1.13B▲ +57.3% YoY
Gross Margin (TTM)
27.5%▲ +3.3% YoY
Operating Income (TTM)
$266M▲ +57.3% YoY
Free Cash Flow (TTM)
$184M▲ +57.3% YoY
About INSMED INC
A company profile for INSMED INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
49/100
Analyst Price Target
ⓘAverage Target
$137.60
▲ +3.8% Upside
High Target$158.07
Low Target$106.54
Based on 14 analysts
Latest News & Updates
🚀
MarketWatch·2h ago
INSMED INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Reuters·5h ago
Analysts lift INSM price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
CNBC·1d ago
INSMED INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.